Hypo gammaglobulinemia (gG) after lung transplantation: impact of non specific gG replacement on infection and rejection

C. Pison, C. Découchon, B. Coltey, I. Pin, C. Chevallier, O. Chavanon, C. Sessa, D. Blin (Grenoble, France)

Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Session: Bronchiolitis obliterans: diagnosis and treatment
Session type: Oral Presentation
Number: 1353

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Pison, C. Découchon, B. Coltey, I. Pin, C. Chevallier, O. Chavanon, C. Sessa, D. Blin (Grenoble, France). Hypo gammaglobulinemia (gG) after lung transplantation: impact of non specific gG replacement on infection and rejection. Eur Respir J 2003; 22: Suppl. 45, 1353

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

The humoral immune response to influenza vaccination in lung transplant patients
Source: Eur Respir J 2001; 18: 971-976
Year: 2001



Cytomegalovirus (CMV) infection – Correlation between CMV-DNA PCR in bronchoalveolar lavage (BAL), CMV pp65 antigen load in PBMCs and clinical symptoms in lung transplant recipients
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005

Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx)
Source: Eur Respir J 2006; 28: Suppl. 50, 777s
Year: 2006

Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Cytomegalovirus (CMV) damage of the lungs associated with pulmonary tumours: is it a fortuitousness or a rule?
Source: Eur Respir J 2003; 22: Suppl. 45, 249s
Year: 2003

Late-breaking abstract: Non specific IgG replacement in lung transplantation recipients with low IgG plasma levels: Effects on survival and bronchiolitis obliterans syndrome occurrence
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011

TB in the immunocompromised host
Source: Eur Respir Mon 2012; 58: 230-241
Year: 2012


The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD)
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

The content of IgE and circulating immune complexes (CIC) in pregnant women with exacerbation of chronic simple bronchitis due to cytomegalovirus infection
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Immunodeficiencies associated with bronchiectasis
Source: Eur Respir Mon 2011; 52: 178-191
Year: 2011


Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection?
Source: Eur Respir J 2002; 20: 165-169
Year: 2002



Lymphoma's and rejection after lung transplantation: balancing the immunosuppression
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005

Changing in the content of antiphospholipid antibodies during exacerbation of chronic simple bronchitis caused by reactivation of chronic cytomegalovirus infection (CMVI) in women in the second trimester of pregnancy
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017

Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


C-reactive protein (CRP) levels in children infected with the human immunodeficiency virus (HIV), with and without acute respiratory infection
Source: Eur Respir J 2003; 22: Suppl. 45, 142s
Year: 2003